Alpha Teknova, Inc. (TKNO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alpha Teknova, Inc. (TKNO:NASDAQ), powered by AI.

Current Price
$4.96
P/E Ratio
-15.4
Market Cap
265M
Sector
Healthcare
What is the Alpha Teknova, Inc. stock price forecast?

Alpha Teknova, Inc. is currently trading at $4.96. View real-time AI analysis on Alpha Lenz.

What is Alpha Teknova, Inc. insider trading activity?

View the latest insider trading data for Alpha Teknova, Inc. on Alpha Lenz.

What is Alpha Teknova, Inc.'s P/E ratio?

Alpha Teknova, Inc.'s P/E ratio is -15.4.

Alpha Teknova, Inc.

NASDAQ · TKNO
$4.96-0.13(-2.55%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Alpha Teknova, Inc.'s future dividend policy...
Alpha Chat Insight

Alpha Teknova, Inc. trades at a P/E of -15.4 (undervalued) with modest ROE of -22.8%.

Ask for details

Company Overview

Alpha Teknova, Inc. is a biotechnology company that specializes in developing and manufacturing critical reagents and materials used in various stages of scientific research and production. Primarily serving the life sciences industry, the company's offerings include media and buffers, liquid-handling tools, and molecular components essential for laboratory assays and diagnostic tests. Alpha Teknova plays a crucial role in supporting pharmaceutical companies, diagnostics firms, and academic institutions, facilitating advancements in research and development. The company’s products are vital in applications such as cell culture, protein and nucleic acid detection, and high-throughput screening. By providing customized and high-quality solutions, Alpha Teknova helps optimize workflows in laboratories, thus accelerating innovation and discovery in the biotechnology sector. Through its contributions, the company is an integral part of the supply chain that underpins scientific breakthroughs and medical advancements.

CEOMr. Stephen Gunstream
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees173

Company Statistics

FY 2025

Profile

$265.28MMarket Cap
$40.52MRevenue
0.00Shares Out
173Employees

Margins

33.17%Gross
-26.24%EBITDA
-41.90%Operating
-42.45%Pre-Tax
-42.59%Net

Valuation

-15.37P/E
3.86P/B
6.55EV/Sales
-27.05EV/EBITDA
-27.09P/FCF

Growth (CAGR)

-0.73%Rev 3Yr
5.30%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.52%ROA
-22.83%ROE
-14.83%ROIC

Financial Health

$5.91MCash & Cash Equivalents
$28.90MNet Debt
50.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Alpha Teknova, Inc. (ticker: TKNO) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 173 employees. Market cap is $265M.

The current price is $4.96 with a P/E ratio of -15.37x and P/B of 3.86x.

ROE is -22.83% and operating margin is -41.90%. Annual revenue is $41M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Alpha Teknova, Inc. (TKNO) Stock Forecast 2026 $4.96 — Price, Financials & Analyst Targets | Alpha Lenz